The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C seeks to track the MSCI ACWI IMI Genomic Innovation Select Screened 100 index. The MSCI ACWI IMI Genomic Innovation Select Screened 100 index tracks stocks from developed and emerging countries worldwide. The index selects companies that are expected to derive revenue from technological innovations in the genomic healthcare sector. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance). The parent index is the MSCI ACWI IMI.